| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |